Delivery Order SPE2DB22D9316-SPE2DB25FYP01
Award Date
5/12/25
Potential Completion Date
6/3/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the supply of CEREZYME 400 unit vials, with an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.60, is for the delivery of CEREZYME 400 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant single-award indefinite delivery contract (IDC) with the DLA, valued at up...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $14,418.03, is for the delivery of 4,567,903 units of CEREZYME 400 UNIT VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of April 22, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $14,418.03, is for the delivery of 4,568,295,693 units of the pharmaceutical product CEREZYME 400 UNIT VIALS. The contract has a firm fixed price and is set to be completed by May 22, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,878,290 units of CEREZYME 400 UNIT VIALS. The contract, valued at $7,881.60, has a period of performance through June 25, 2024. DMS Pharmaceutical Group Inc. is registered in the System for Award Management (SAM.gov) and has a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $13,136.00 contract is for the delivery of CEREZYME 400 UNIT VIALS, a pharmaceutical product, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, valued up to $4,999,999 through 2025, for a broad range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,418.03, is for the delivery of CEREZYME 400 UNIT VIALS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc., valued at $499,999,999 and valid through November 2026. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $14,418.03 and covers the delivery of CEREZYME 400 UNIT VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a diverse array of branded and generic prescription...
This is a $22,471.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cerezyme 400 unit vials, with a performance period through November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...